Drug level in human liver microsomes treated with 2 and 20 uM brivanib for 30 mins by LC/MS analysis in presence of 10 uM CYP2C9 inhibitor sulfaphenaz...

Basic Information

ID: ALA3534805

Type: ADME

Description: Drug level in human liver microsomes treated with 2 and 20 uM brivanib for 30 mins by LC/MS analysis in presence of 10 uM CYP2C9 inhibitor sulfaphenazole

Format: BAO_0000019

Organism: Homo sapiens

Tissue: Liver

Target: Liver microsome(ALA2367379)

Document: ALA3526086

Drug level in human liver microsomes treated with 2 and 20 uM brivanib for 30 mins by LC/MS analysis in presence of 10 uM CYP2C9 inhibitor sulfaphenazole: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA3534805

Drug metabolism

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
386.38	2.70	2.70

Parent Molecular Weight

ALogP

Polar Surface Area

386.38

2.70

Drug level in human liver microsomes treated with 2 and 20 uM brivanib for 30 mins by LC/MS analysis in presence of 10 uM CYP2C9 inhibitor sulfaphenaz...

Basic Information

Activity Charts

Compound Summary